Elevated Tau in Military Personnel Relates to Chronic Symptoms Following Traumatic Brain Injury.
Adult
Amyloid beta-Peptides
/ blood
Biomarkers
/ blood
Brain Injuries, Traumatic
/ blood
Cohort Studies
Cross-Sectional Studies
Depressive Disorder
/ blood
Female
Humans
Male
Middle Aged
Military Personnel
/ psychology
Neurofilament Proteins
/ blood
Post-Concussion Syndrome
/ blood
Stress Disorders, Post-Traumatic
/ blood
Veterans
/ psychology
Young Adult
tau Proteins
/ blood
Journal
The Journal of head trauma rehabilitation
ISSN: 1550-509X
Titre abrégé: J Head Trauma Rehabil
Pays: United States
ID NLM: 8702552
Informations de publication
Date de publication:
Historique:
pubmed:
30
4
2019
medline:
6
7
2021
entrez:
30
4
2019
Statut:
ppublish
Résumé
To understand the relationships between traumatic brain injury (TBI), blood biomarkers, and symptoms of posttraumatic stress disorder (PTSD), depression, and postconcussive syndrome symptoms. Cross-sectional cohort study using multivariate analyses. One hundred nine military personnel and veterans, both with and without a history of TBI. PTSD Checklist-Civilian Version (PCL-C); Neurobehavioral Symptom Inventory (NSI); Ohio State University TBI Identification Method; Patient Health Questionnaire-9 (PHQ-9); Simoa-measured concentrations of tau, amyloid-beta (Aβ) 40, Aβ42, and neurofilament light (NFL). Controlling for age, sex, time since last injury (TSLI), and antianxiety/depression medication use, NFL was trending toward being significantly elevated in participants who had sustained 3 or more TBIs compared with those who had sustained 1 or 2 TBIs. Within the TBI group, partial correlations that controlled for age, sex, TSLI, and antianxiety/depression medication use showed that tau concentrations were significantly correlated with greater symptom severity, as measured with the NSI, PCL, and PHQ-9. Elevations in tau are associated with symptom severity after TBI, while NFL levels are elevated in those with a history of repetitive TBIs and in military personnel and veterans. This study shows the utility of measuring biomarkers chronically postinjury. Furthermore, there is a critical need for studies of biomarkers longitudinally following TBI.
Identifiants
pubmed: 31033745
doi: 10.1097/HTR.0000000000000485
pmc: PMC6814502
mid: NIHMS1517748
pii: 00001199-202001000-00007
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
Neurofilament Proteins
0
neurofilament protein L
0
tau Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-73Subventions
Organisme : Intramural NIH HHS
ID : Z99 NR999999
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Dialogues Clin Neurosci. 2011;13(3):287-300
pubmed: 22033563
Neuron. 2016 Jul 6;91(1):1-3
pubmed: 27387643
PLoS One. 2012;7(12):e52169
pubmed: 23284921
Alzheimers Dement. 2014 Jun;10(3 Suppl):S242-53
pubmed: 24924675
Curr Psychiatry Rep. 2017 Sep 19;19(11):81
pubmed: 28924828
Chronic Stress (Thousand Oaks). 2017 Jan;1:
pubmed: 28845475
Injury. 2011 Mar;42(3):288-300
pubmed: 21216400
Front Neurol. 2017 Jul 03;8:300
pubmed: 28717351
Brain Inj. 2016;30(3):287-94
pubmed: 26910483
JAMA Psychiatry. 2013 Jul;70(7):686-91
pubmed: 23676987
Brain. 2017 Jul 1;140(7):2041-2050
pubmed: 28582479
Ageing Res Rev. 2017 Mar;34:51-63
pubmed: 27829172
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1137-1142
pubmed: 27492070
Acta Neuropathol. 2015 Jul;130(1):21-34
pubmed: 25943889
J Head Trauma Rehabil. 2011 Mar-Apr;26(2):103-15
pubmed: 20631631
JAMA Neurol. 2014 Jun;71(6):684-92
pubmed: 24627036
NeuroRehabilitation. 1996;6(3):193-201
pubmed: 24525771
Front Cell Neurosci. 2014 Dec 17;8:429
pubmed: 25565963
JAMA Neurol. 2016 Nov 01;73(11):1308-1315
pubmed: 27654934
J Clin Psychol. 2012 Jun;68(6):699-713
pubmed: 22517497
J Neurotrauma. 2017 Jul 15;34(14):2206-2219
pubmed: 27198861
Front Mol Neurosci. 2015 Aug 14;8:44
pubmed: 26321907
J Head Trauma Rehabil. 2014 Jan-Feb;29(1):1-10
pubmed: 23474880
Brain. 2017 Dec 1;140(12):3286-3300
pubmed: 29053874
J Head Trauma Rehabil. 2007 Nov-Dec;22(6):318-29
pubmed: 18025964
Sci Rep. 2016 Nov 07;6:36791
pubmed: 27819296
JAMA Neurol. 2015 Oct;72(10):1109-16
pubmed: 26237304
Brain Inj. 2016;30(12):1436-1441
pubmed: 27834544
J Neurosci. 2017 Mar 15;37(11):3085-3101
pubmed: 28188216
Front Psychiatry. 2015 Jul 22;6:104
pubmed: 26257660
Brain Inj. 2013;27(4):425-33
pubmed: 23473386
J Neurotrauma. 2018 Jul 23;:
pubmed: 29690824
J Rehabil Res Dev. 2012;49(6):879-88
pubmed: 23299259
PLoS One. 2012;7(4):e33606
pubmed: 22496755
Med Care. 2012 Apr;50(4):342-6
pubmed: 22228249
Brain Sci. 2017 Jul 09;7(7):
pubmed: 28698487
J Neurotrauma. 2016 Jun 1;33(11):1084-101
pubmed: 26715144
Ann Clin Transl Neurol. 2016 Jul 01;3(8):623-36
pubmed: 27606344
Neurobiol Dis. 2015 Feb;74:58-65
pubmed: 25447235
J Alzheimers Dis. 2016;51(4):1099-109
pubmed: 26890775
J Neurotrauma. 2016 Oct 1;33(19):1784-1789
pubmed: 26700106
Neurology. 2017 Feb 7;88(6):595-602
pubmed: 28062722
PLoS One. 2015 Jul 02;10(7):e0132177
pubmed: 26136237
Appl Neuropsychol Adult. 2018 Mar-Apr;25(2):126-136
pubmed: 27929660
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
JAMA Neurol. 2017 Sep 1;74(9):1073-1080
pubmed: 28692710
Ann N Y Acad Sci. 2015 May;1345:89-98
pubmed: 25809391
Ann Clin Transl Neurol. 2015 Jul;2(7):748-55
pubmed: 26273687
J Neurotrauma. 2017 Aug 15;34(16):2475-2479
pubmed: 28385104